In partnership with

Today’s edition is sponsored by Marketing Against the Grain. Their support keeps these briefings free and focused on what actually matters. Interested in seeing your company or brand here? Sponsor an edition.

Three state-licensed medical cannabis operators asked a federal appeals court to stay DEA’s November 29th supply-chain deadline, and Massachusetts regulators say no federal agency has given them guidance on DEA registration. A federal judge declined to pause Illinois’s dispensary-only rule for intoxicating hemp, and with the federal cap set for December 11th, Minnesota is preparing for either outcome while Kentucky’s governor wants the state left to regulate. Draft Senate spending reports would keep cannabis drug testing as it is, a Virginia commission wants to shrink a $250 public-use fine, Philadelphia’s City Council is pressing Pennsylvania to legalize, and Indiana’s secretary of state-elect wants citizens to be able to put cannabis on the ballot. Plus Missouri, Hawaii, Utah, Michigan, and Colorado.

⚖️ DEA in court
🚛 Drug testing stays
🧾 Virginia’s $250 fine
🗳️ Indiana ballot push

❝

A government of laws and not of men.

John Adams, Massachusetts Constitution, Declaration of Rights, Article XXX (1780)

Three state-licensed medical cannabis companies asked a federal appeals court Wednesday to block a DEA directive that gives cannabis businesses until November 29th to buy from and sell to only operators that have been granted federal registration or applied for it on time. Lawyers for Standard Wellness Utah, Verde Americano in Arizona, and NW Confections OK in Oklahoma filed a petition for review in the U.S. Court of Appeals for the D.C. Circuit, docketed as Standard Wellness Utah, LLC v. DEA, No. 26-1324, and want a ruling or an administrative stay before November 25th. The companies are represented by Shane Pennington of Blank Rome, who had been slated for my IgniteIt panel earlier this week and had to bow out. Now we know why! They are challenging an October 30th document titled “DEA Medical Marijuana Timely Applicant Information.” The petition says it contradicts the April order from Attorney General Todd Blanche that moved state-licensed medical cannabis to Schedule III and set up DEA’s registration process for it, an order the companies say lets early applicants operate under their state licenses while their applications are pending. It also argues that the document is a legislative rule issued without public notice and comment, and that it is arbitrary and capricious because DEA gave 30 days’ notice without weighing what severing trading relationships would cost.

The filing says the effects have already started, too. According to the petition, Standard Wellness Utah stands to lose monthly sales averaging about $275,900 and the suppliers of about 16% of its oil, NW Confections expects its Oklahoma business to become insolvent, and Verde expects to cut about 70% of its workforce. The petition says the deadline “ignores the realities of state markets, which prohibit interstate commerce,” and that DEA has not answered the companies’ request to suspend it. Separately, DEA has sent orders to show cause, a step that can lead to denial but is not a final decision, to applicants in California, Delaware, Illinois, Minnesota, North Dakota, and Oregon, plus Washington, D.C. This felt somewhat inevitable as rescheduling attempts to wedge federal bureaucracy and process into existing, and disparate, state supply chain activity. It was always more likely this would get implemented in a choppy way, through lawsuits. Don’t like the hand you’re dealt? Sue. Anyone tracking November 25th and November 29th can keep both on the Deadlines, Decoded calendar. (Marijuana Moment)

📮 The Massachusetts Cannabis Control Commission told licensees in a bulletin this week that it “has not received implementation guidance from any federal agencies regarding these developments” and cannot advise on DEA registration requirements or on how federal law applies to any one business. The bulletin passed along DEA’s published list of timely medical applicants for information only, and it said the commission cannot give legal, tax, or business advice. The commission’s administration of state requirements is unchanged, because the federal developments “do not change the Commission’s administration of Massachusetts cannabis laws and regulations.” Massachusetts isn’t alone. Maine’s cannabis office told its medical program it hasn’t gotten any federal guidance either, and Maryland is telling its businesses that state law hasn’t changed. In other words, regulators are telling licensees what everyone already knew: DEA hasn’t talked to the states. (The Marijuana Herald; Maine Office of Cannabis Policy; Maryland Cannabis Administration)

About three weeks before the federal cap takes hold, Minnesota’s top cannabis regulator says intoxicating hemp products stay legal under state law whatever Congress does. The cap allows no more than 0.4 milligrams per container of total THC and similar-effect cannabinoids combined. Cannabinoids the plant cannot make naturally already fell out of the hemp definition on November 12th, and naturally occurring ones made outside the plant follow on December 11th. Eric Taubel, director of the Office of Cannabis Management, told the Minnesota Reformer that fewer retailers will probably stock these products, that his office has received no federal guidance on how the law will be interpreted or enforced, and that it is preparing for either outcome. Taubel put the business side plainly: “Every business is going to make a series of calculations about what risk they’re willing to tolerate.” Wild State Cider’s Ryan Kopperud says every tier of the state’s system is drawing up Minnesota-only contingency plans, with ATMs going into taprooms so customers can pay cash for hemp beverages, and wholesaler Bellboy’s Keith Donovan says its hemp sales fell about 75% from September to October. Minnesota looks poised to be a sort of hemp safe haven, but one with the same challenges a marijuana market faces. What’s your risk tolerance?

In Washington, outgoing Sen. Tina Smith backs reversing the cap, and Sen. Amy Klobuchar, who is also Minnesota’s governor-elect, joined Sen. Tim Sheehy of Montana on Tuesday to introduce the Hemp Guardrails Act, her third hemp bill of the session. None has moved. Sen. Ted Budd of North Carolina says he will not support any year-end package that “extends, delays, or builds a regulatory framework” around these products, and Sen. Pete Ricketts of Nebraska says ditto. Congress doing nothing is still the safest bet before December 11th. Kentucky’s governor has a different complaint. Gov. Andy Beshear said at his weekly update, “I am concerned about the ban. This is something they should let us regulate here in Kentucky.” (Minnesota Reformer; Marijuana Moment; WLKY)

🏛️ Illinois can now enforce its intoxicating hemp limit against every seller. U.S. District Judge Martha M. Pacold of the Northern District of Illinois on Thursday denied a temporary restraining order sought by the Illinois Healthy Alternatives Association and several hemp businesses, without prejudice, so their request for a preliminary injunction is still pending. The state’s agreement not to enforce the Illinois Hemp Act against the plaintiffs and the association’s members expired yesterday. The law treats hemp products with more than 0.4 milligrams of total THC per container as cannabis that only licensed dispensaries may sell, taking them off the shelves at gas stations, convenience stores, breweries, and hemp cafés. State officials cite children’s access, and the association is “exploring review in the appellate court.” The next court date is December 15th. Illinois hemp businesses were dealt a blow with the denied TRO, but the request always felt like a negotiating tactic. (NBC Chicago; Axios Chicago; FOX 32 Chicago)

The Senate Appropriations Committee posted draft fiscal year 2027 spending bills and the reports that accompany them Monday, and three of them touch cannabis. The report on the transportation and housing bill directs the Department of Transportation to “maintain current drug testing requirements for cannabis” for truck drivers, airline pilots, and other safety-sensitive workers even after rescheduling, adding, “In the absence of a scientifically validated threshold correlating cannabis metabolite levels with impairment, relaxing testing requirements could compromise workforce safety and regulatory consistency.” It also urges the department to work with HHS and NHTSA on improved impairment detection methods. The financial services bill carries forward the rider that bars the District of Columbia from legalizing and regulating adult-use sales, and its report reminds the District that federal law adds penalties for distribution near schools, a warning aimed at existing medical dispensaries. The Labor-HHS report says Schedule I status undermines research, encourages NIH to expand psychedelic research, and asks CMS to report on hospital costs related to cannabis use.

A positive test tells you someone used cannabis, not that they’re impaired right now, and the committee’s own wording says as much. Pilots and truck drivers should face stricter rules than most, but the fix is better impairment testing, which the report also asks for, not leaning harder on a metabolite. (Marijuana Moment)

🔬 Missouri’s rule for cannabis research licenses takes effect November 30th, and the Division of Cannabis Regulation is surveying prospective applicants on what they want to study and what could stand in their way. Research licensees may sell or transfer seeds and clones from an approved study to licensed cultivators, but cannabis sold to consumers must still be grown in a licensed cultivation facility. Division director Amy Moore has said the rules leave room for many kinds of research, and a one-hour overview webinar is set for December 7th. The licenses trace to the constitutional amendment voters approved in 2022. Surveying applicants first is smart. Missouri is likely concerned about the same things we were in Massachusetts, since research is a generic term for a lot of things. We also flagged the trade secret risk of a company’s R&D somehow becoming a public record. (Missouri DHSS; Missouri Independent)

A legislative commission is moving to soften a Virginia penalty before it takes effect. The Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market met Monday and recommended reducing the civil penalty for public cannabis consumption, which is set to rise from a maximum of $25 to a maximum of $250 on July 1st, the day retail sales begin. It did not name a replacement figure. The commission also recommended removing the financial penalty for youth public consumption. Separately, staff at the Division of Legislative Services proposed in a presentation to the commission that no one be prosecuted for both public consumption and consumption on school grounds for the same act. The same staff deck proposes clarifying how far localities can go on store distance rules and business hours.

Del. Katrina Callsen (D-Albemarle) said she wants any fine “tied to the efficiency and ability of police to enforce the laws as we’ve written them,” citing a conversation with a police chief. The recommendations go to the General Assembly in next year’s session, and unless lawmakers act, the higher fine takes effect the day the first stores open. It’s nice to see Virginia worried about small fines and youth public consumption. It might also consider figuring out how to stand up its market, and how to shorten its acronyms. JCOTCCRM doesn’t exactly roll off the tongue. (WRIC; Division of Legislative Services)

🏥 Hawaii Sen. Joy San Buenaventura chairs the Senate Health and Human Services Committee. She told The Marijuana Herald that federal rescheduling appears to remove the blocks to Ryan’s Law, which would let patients keep using medical cannabis while in a hospital. She cosponsored SB 2408, which passed the Senate unanimously in March. It cleared the House Health Committee before stalling in the House Judiciary and Hawaiian Affairs Committee on April 1st. She has no specific bill in mind for 2027, and she also wants custody protections for medical patients and a low-potency cannabis bill after a version failed this year. The Herald notes that Schedule III does not by itself authorize hospital use. Another state weighing hospital access for patients is encouraging to see. (The Marijuana Herald)

Philadelphia’s City Council passed a resolution by voice vote urging the Pennsylvania General Assembly to enact adult-use cannabis legislation once Democrats control both chambers. Their 26-24 Senate majority takes over when the new session opens January 5th. Council President Kenyatta Johnson, Councilmember Jim Harrity, and eight colleagues sponsored the resolution, and it calls the new majorities “a rare opportunity to enact comprehensive adult-use cannabis legislation” after years of stalled efforts in a divided Senate. The state’s own leaders are less urgent. Sen. Jay Costa (D), the Democratic caucus’s nominee for Senate president pro tempore, a post the full Senate fills when the session opens, told WHTM, “It’s not maybe necessarily one of the high priority items that we feel like we’ve been given a clear responsibility to address.” Gov. Josh Shapiro, a longtime supporter, left legalization out of the preview of his 100-day plan, according to WHYY.

The disagreement that stalled the issue before is still there. A House-passed bill from last year would have put sales in state-run stores overseen by the Liquor Control Board. SB 120, a bipartisan Senate bill from Sen. Dan Laughlin (R) and Sen. Sharif Street (D), would let licensed medical dispensaries add adult-use sales with a dual-use permit that carries a $100,000 application fee and an 8% excise tax on the retail price, and it never got out of committee. A Quinnipiac poll this year found 56% of registered voters support legalization. So the bills are already written. The hard part, same as before, is getting Harrisburg to agree on one. We have an upcoming episode of The Hybrid focused on Pennsylvania’s potential, and we’ll get into exactly these specifics there. (Marijuana Moment; WHYY)

🩺 A Utah advisory group wants doctors to be able to recommend cannabis for any condition they think it could help, including sleep disturbances, generalized anxiety disorder, and major depressive disorder. The Industry Committee of the state’s Medical Cannabis Policy Advisory Board ranks the idea among its top priorities for 2027, alongside telehealth access, medical cards valid for two years instead of one, and changes to processor licensing. Utah recognizes 16 qualifying conditions now, and patients with anything else go to the Compassionate Use Board one case at a time. For now it’s a committee wish list, not a board vote or a bill, and the Legislature gets the final say. (The Marijuana Herald)

Indiana Secretary of State-elect Beau Bayh (D) wants to amend the state constitution so voters can put initiatives on the ballot, cannabis legalization among them. Indiana has no citizen initiative now, which means only the legislature can end prohibition, and leaders of the Republican majority have shown no willingness to do it, even for medical use. Asked by the Evansville Courier & Press whether legalization is the kind of issue voters should be able to act on, Bayh said, “I support putting that on the ballot and letting people decide.” The route is long: both chambers would have to approve an amendment in two successive sessions before it goes to voters. Bayh says he has already talked with legislators about a bill in the next session and says, “I want it to be bipartisan, so it can’t just be Democrats carrying the legislation.”

Polling gives him something to point to. The Ball State Hoosier Survey in January found 59% of residents back legalizing cannabis for medical and adult use, and 84% back some form of it. Gov. Mike Braun (R) calls himself agnostic on legalization generally but says Indiana is surrounded by four states with medical programs and “we need to look at it seriously.” An initiative process is an awkward way to write law, though it is how Massachusetts voters legalized adult-use cannabis (and recently rejected an attempted repeal). The catch is that the amendment has to get through the same legislature that has shown no interest in acting, twice, before voters ever see it. (Marijuana Moment)

🗺️ Around the map: Missouri’s legal cannabis industry has generated $992.02 million in sales taxes through October, including $609.19 million for the state and $382.82 million for localities, according to the Missouri Cannabis Trade Association. Michigan collected $287.2 million in adult-use cannabis excise taxes in fiscal year 2025-26, not counting its separate 24% wholesale tax, about 68% more than the $171.4 million from beer, wine, and liquor excise taxes combined, per the House Fiscal Agency. Colorado has sent $703.5 million of the $851.9 million in cannabis excise taxes collected from fiscal year 2013-14 through 2025-26 to the fund for public school construction, according to Joint Budget Committee staff. In Virginia, the Round Hill Town Council set a 3.5% local cannabis sales tax, the highest state law allows, and sent zoning rules to its Planning Commission, with a joint public hearing set for January 6th. (KOMU; The Marijuana Herald; Loudoun Now)

Claude Hacks For Marketers

The marketers pulling ahead right now are not using better tools. They have better systems. The 60 Claude Workflows prompt pack from Marketing Against the Grain gives you ready-to-use instructions built for content production, strategic planning, and campaign execution. Subscribe and get the full pack free.

Inside you will find:

  • 60 ready-to-use Claude prompts built for real marketing workflows.

  • Workflows for content, strategy, competitive analysis, and campaign execution

  • Prompts designed to drop directly into work you are already doing

  •  Instructions built for execution, not experimentation

The fastest marketers are not experimenting with AI. They are running it like a system. Get the prompt pack free when you subscribe today.

Deadlines, Decoded, the monthly companion to Policy, Decoded. Every cannabis and hemp effective date, in one place. Free and monthly, by email. Sign up.

SHARE THE BRIEFING

Policy, Decoded grows best when it's shared deliberately. Refer three people and you get 30 minutes with me, one on one, on whatever policy issue is actually in front of you. One referral earns a sticker pack, five earns How to Be Heard, our guide to making public comment that regulators actually read, and ten earns the Field Kit.

Policy, Decoded is compiled and edited by Shawn Collins of THC Group. AI tools help with research and source checks; the judgments are his.
How we use AI: https://policy.homegrown-group.com/ai

Get the briefing free, every weekday morning.

Recommended for you

View all
caret-right